Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Chronic Pancytopenia and Increased Bone Density Due to TBXAS1 Deficiency

Richa Sharma, MD, Jennifer E. Schwartz, MD FRCP(C), Grzegorz Nalepa, MDPhD

Blood (2016) 128 (22): 1503.

https://doi.org/10.1182/blood.V128.22.1503.1503

Published: 2016

Journal Articles

Single Center Retrospective Comparison of Gvhd Preventive Regimens after Cy/Flu Minimal Intensity Allotransplantation

Praveen Ranganath, MBBS, Michael J. Robertson, MD, Rafat Abonour, MD, Jennifer E. Schwartz, MD FRCP(C), Sherif Farag, MBBS, PhD, Lisa l Wood, RN, Patrick Kiel, PharmD, Robert Nelson

Blood (2014) 124 (21): 5874.

https://doi.org/10.1182/blood.V124.21.5874.5874

Published: 2014

Journal Articles

The Outcome of the Combination of Tacrolimus, Sirolimus, and ATG for GvHD Prophylaxis on Allogeneic Stem Cell Transplantation From Matched Unrelated Donors

Yaser Homsi, MD, Dareen Alwan, MD, Patrick Kiel, PharmD, Lindsay Rosenbeck, PharnD, Srivastava Shivani, MD, Jennifer E. Schwartz, MD, FRCP(C), Robert P. Nelson, Jr., MD, Rafat Abonour, MD, Michael Robertson, MD, Sherif Farag, MD, PhD, FRACP, FRCPA

Blood (2010) 116 (21): 2345.

https://doi.org/10.1182/blood.V116.21.2345.2345

Published: 2010

Journal Articles

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide: A Novel Preparative Regimen Prior to Autologous Peripheral Blood Stem Cell (PBSC) Transplantation in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma.

Sherif Farag, MD, PhD, Lisa L Wood, RN, Shivani Srivastava, MD, Robert P. Nelson, Jr., MD, Jennifer E. Schwartz, MD, FRCP(C), Elizabeth Cox, Rafat Abonour, MD, Michael Robertson, MD,

Blood (2009) 114 (22): 3402.

https://doi.org/10.1182/blood.V114.22.3402.3402

Published: 2009

Journal Articles

Phase I Trial of High-Dose Clofarabine and Busulfan as a Myeloablative Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia.

Sherif Farag, MD, PhD, Lisa L Wood, RN, Jennifer E. Schwartz, MD, FRCP(C), Shivani Srivastava, MD, Robert P. Nelson, Jr., MD, Michael Robertson, MD, Rafat Abonour, MD, Hamid Sayar, MD, Larry D. Cripe, MD

Blood (2009) 114 (22): 198.

https://doi.org/10.1182/blood.V114.22.198.198

Published: 2009

Journal Articles

Infusion of Large Number of Circulating Myeloma Cells Does Not Influence the Survival of Patients Undergoing Autologous Stem Cell Transplantation.

Rafat Abonour, Hayley Knollman, Attaya Suvannasankha, MD, Menggang Yu, Rebecca Britton, Shivani Srivastava, MD, Robert P. Nelson, Jr., MD, Jennifer E. Schwartz, MD, FRCP(C), Michael Robertson, MD, Kenneth Cornetta, MD, Sherif Farag, MBBS, PhD

Blood (2009) 114 (22): 1224.

https://doi.org/10.1182/blood.V114.22.1224.1224

Published: 2009

Journal Articles

T Regulatory Cells in Graft-Versus-Host Disease of the Skin

Jose Azar, MD, Steven Billings, MD, Jennifer E. Schwartz, MD, FRCP(C), Yunlong Liu, Menggang Yu, Robert P. Nelson

Blood (2008) 112 (11): 4354.

https://doi.org/10.1182/blood.V112.11.4354.4354

Published: 2008

NARROW

Chronic Pancytopenia and Increased Bone Density Due to TBXAS1 Deficiency

Single Center Retrospective Comparison of Gvhd Preventive Regimens after Cy/Flu Minimal Intensity Allotransplantation

The Outcome of the Combination of Tacrolimus, Sirolimus, and ATG for GvHD Prophylaxis on Allogeneic Stem Cell Transplantation From Matched Unrelated Donors

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide: A Novel Preparative Regimen Prior to Autologous Peripheral Blood Stem Cell (PBSC) Transplantation in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma.

Phase I Trial of High-Dose Clofarabine and Busulfan as a Myeloablative Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia.

Infusion of Large Number of Circulating Myeloma Cells Does Not Influence the Survival of Patients Undergoing Autologous Stem Cell Transplantation.

T Regulatory Cells in Graft-Versus-Host Disease of the Skin

Email alerts

ASH Publications

American Society of Hematology

Chronic Pancytopenia and Increased Bone Density Due to TBXAS1 Deficiency

Single Center Retrospective Comparison of Gvhd Preventive Regimens after Cy/Flu Minimal Intensity Allotransplantation

The Outcome of the Combination of Tacrolimus, Sirolimus, and ATG for GvHD Prophylaxis on Allogeneic Stem Cell Transplantation From Matched Unrelated Donors

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide: A Novel Preparative Regimen Prior to Autologous Peripheral Blood Stem Cell (PBSC) Transplantation in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma.

Phase I Trial of High-Dose Clofarabine and Busulfan as a Myeloablative Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia.

Infusion of Large Number of Circulating Myeloma Cells Does Not Influence the Survival of Patients Undergoing Autologous Stem Cell Transplantation.

T Regulatory Cells in Graft-Versus-Host Disease of the Skin

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only